The definitive source for pharmaceutical cold chain compliance
Practical resources for pharmaceutical distributors and 3PLs navigating state licensing requirements, DSCSA obligations, and regulatory compliance.
State Licensing Guides cover the application process, fees, bonding requirements, designated representative qualifications, and renewal timelines for each state's board of pharmacy.
DSCSA Compliance Guides explain Drug Supply Chain Security Act requirements including transaction documentation, verification obligations, and the 2026 enhanced serialization deadline.
Complete guide for independent pharmacies on choosing and verifying wholesale drug distributors. Learn verification steps, NABP accreditation importance, DSCSA compliance requirements, and red flags to avoid illegitimate suppliers.
+44 more — switch to the State Licensing tab to see all.
Small dispensers have nine months to achieve full DSCSA enhanced drug distribution security compliance by November 27, 2026. This guide covers who qualifies as a small dispenser, what's exempted versus already required, technology requirements, a month-by-month preparation timeline, cost estimates, and enforcement penalties.
Wholesale drug distributors must verify Authorized Trading Partner (ATP) status under DSCSA before transacting with manufacturers, other distributors, and dispensers. This guide covers ATP verification methods, documentation requirements, and compliance steps for wholesale distributors subject to full DSCSA enforcement as of August 27, 2025.
DSCSA serialization requirements for wholesale distributors became fully enforceable on August 27, 2025. Distributors must now verify product identifiers on receipt, exchange serialized transaction data via EPCIS, and confirm saleable returns with manufacturers before redistribution.
The FDA's enforcement discretion period for wholesale drug distributors ended August 27, 2025. All distributors must now comply with DSCSA Section 582(g)(1) enhanced requirements: serialized package-level data exchange, product identifier verification, and interoperable electronic systems. FDA is actively issuing 483 observations citing DSCSA violations.
+2 more — switch to the DSCSA tab to see all.
DSCSA compliance costs for small wholesale drug distributors range from $10,000 to $500,000 in first-year expenses. This guide breaks down actual costs across three operational models, hidden expenses most distributors miss, vendor pricing by budget tier, and a 90-day implementation plan.
DSCSA enforcement created a comply-or-exit dynamic for small distributors. The EU FMD precedent: 340 wholesaler exits in 2 years, 85% acquired. ColdChainCheck data shows 72% of tracked entities in the vulnerable "Fair" compliance tier, predicting 15-20% exits by August 2027.
FDA's DSCSA enforcement is live as of August 2025. NABP aligned Drug Distributor Accreditation criteria with Section 582 in December 2025. Only 63 of 1,275 tracked distributors (4.9%) hold NABP accreditation — creating a compliance gap that may trigger an application surge in 2026.
Full DSCSA enforcement is live for wholesale distributors as of August 2025, with the next deadline — small dispenser compliance — arriving November 27, 2026. This guide compares TraceLink, rfxcel, LSPedia, and SAP ATTP across pricing, features, and organizational fit, with a size-based selection framework for distributors from independent pharmacy to large enterprise. Trading partner compliance status, tracked across 1,275 entities in the ColdChainCheck directory, is an additional variable in technology selection.
+6 more — switch to the Compliance tab to see all.
Guides are reviewed periodically but regulatory requirements change. Always verify directly with state boards and federal agencies before making compliance decisions.